BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31276728)

  • 1. Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine.
    Itoh K; Taniguchi R; Matsuo T; Oguro A; Vogel CFA; Yamazaki T; Ishihara Y
    Neurosci Lett; 2019 Aug; 708():134363. PubMed ID: 31276728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice.
    Itoh K; Ishihara Y; Komori R; Nochi H; Taniguchi R; Chiba Y; Ueno M; Takata-Tsuji F; Dohgu S; Kataoka Y
    Brain Res; 2016 Dec; 1652():1-13. PubMed ID: 27693413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam Suppresses the Infiltration of Neutrophils and Monocytes and Downregulates Many Inflammatory Cytokines during Epileptogenesis in Pilocarpine-Induced Status Epilepticus Mice.
    Matsuo T; Komori R; Nakatani M; Ochi S; Yokota-Nakatsuma A; Matsumoto J; Takata F; Dohgu S; Ishihara Y; Itoh K
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of levetiracetam on status epilepticus-induced neuronal death in the rat hippocampus.
    Lee DS; Ryu HJ; Kim JE; Choi HC; Kim YI; Song HK; Kang TC
    Seizure; 2013 Jun; 22(5):368-77. PubMed ID: 23490457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction.
    Niidome K; Taniguchi R; Yamazaki T; Tsuji M; Itoh K; Ishihara Y
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
    Tumay Y; Altun Y; Ekmekci K; Ozkul Y
    Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy.
    Kanemura H; Sano F; Ohyama T; Aihara M
    Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine and levetiracetam-loaded PLGA nanoparticles prepared by nanoprecipitation method:
    Kandilli B; Ugur Kaplan AB; Cetin M; Taspinar N; Ertugrul MS; Aydin IC; Hacimuftuoglu A
    Drug Dev Ind Pharm; 2020 Jul; 46(7):1063-1072. PubMed ID: 32406290
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of treatment with clinically relevant valproate, carbamazepine, oxcarbazepine, topiramate, lamotrigine and levetiracetam on ovarian folliculogenesis in young rats.
    Cansu A; Gurgen SG; Demirhan YN; Ozkan Kart P; Yildirim M; Alver A; Yeni Lmez E; Sönmez FM
    Epilepsy Res; 2022 Aug; 184():106966. PubMed ID: 35763982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.
    Dambach H; Hinkerohe D; Prochnow N; Stienen MN; Moinfar Z; Haase CG; Hufnagel A; Faustmann PM
    Epilepsia; 2014 Jan; 55(1):184-92. PubMed ID: 24299259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
    Brigo F; Bragazzi N; Nardone R; Trinka E
    Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Inflammation-Related Genes through
    Komori R; Matsuo T; Yokota-Nakatsuma A; Hashimoto R; Kubo S; Kozawa C; Kono T; Ishihara Y; Itoh K
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
    Stepanova D; Beran RG
    Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status epilepticus.
    Santana-Gómez CE; Valle-Dorado MG; Domínguez-Valentín AE; Hernández-Moreno A; Orozco-Suárez S; Rocha L
    Neurochem Int; 2018 Nov; 120():224-232. PubMed ID: 30213635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures.
    Zhang ZJ; Xing GQ; Russell S; Obeng K; Post RM
    Epilepsia; 2003 Dec; 44(12):1487-93. PubMed ID: 14636317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.